"The Beaufort Memorial Keyserling Cancer Center, an affiliate of the Medical University of South Carolina (MUSC Health), offers a full range of cancer screening and treatment services in one convenient location, to make navigating the cancer journey as easy as possible. Accredited by the American College of Surgeons (ACS) as a Community Cancer Center, the Keyserling Cancer Center brings together board-certified surgical, radiation and medical oncology specialists to customize a treatment plan for you. The team is supported by oncology nurses and navigators, physicists, technologists, therapists and others who work closely with patients and their family members to ensure coordinated care in a healing environment."

During the past decade, Keyserling Cancer Center at Beaufort Memorial Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Keyserling Cancer Center at Beaufort Memorial Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 3 trials as a collaborator, "Aptuit" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "SWOG Cancer Research Network" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Keyserling Cancer Center at Beaufort Memorial Hospital" are "Breast Cancer" (2 trials), "Cardiac Toxicity" (1 trials), "Colorectal Cancer" (1 trials) and "Psychosocial Effects of Cancer and Its Treatment" (1 trials). Many other conditions were trialed in "Keyserling Cancer Center at Beaufort Memorial Hospital" in a lesser frequency.

Most popular intervention types in "Keyserling Cancer Center at Beaufort Memorial Hospital" are "Drug" (2 trials), "Biological" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Coreg CR®" (1 trials), "FOLFIRI" (1 trials), "FOLFOX or" (1 trials), "bevacizumab" (1 trials) and "cetuximab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Keyserling Cancer Center at Beaufort Memorial Hospital" are 2 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Keyserling Cancer Center at Beaufort Memorial Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Keyserling Cancer Center at Beaufort Memorial Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Keyserling Cancer Center at Beaufort Memorial Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".